| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jeffrey Parry | Director | $4 | 13 Nov 2023 | ||
| Daley Juliana | Director | $1 | 13 Nov 2023 | ||
| George Kovalyov | Director | $0 | 06 Mar 2024 | ||
| Crystal Muilenburg | Director | 13 Nov 2023 | |||
| BWL Investments Ltd. | 10%+ Owner | 28 Dec 2023 | |||
| GB Capital Ltd. | CFO, Director | 13 Nov 2023 | |||
| Hatem Abou-Sayed MD MBA FACS, a Professional Medical Corp | CMO, Director | 13 Nov 2023 | |||
| Hatem Abou-Sayed | Director | 13 Nov 2023 | |||
| Jordan R. Plews | CEO, Director, 10%+ Owner | 13 Nov 2023 | |||
| JP Bio Consulting LLC | CEO, Director, 10%+ Owner | 13 Nov 2023 | |||
| Brenda Beuchler | Cmo | 13 Nov 2023 | |||
| Chris Kraneiss | Cmo | 13 Nov 2023 | |||
| Braeden Lichti | Director, 10%+ Owner | 26 Mar 2025 | |||
| Graydon Bensler | CEO & CFO, Director, 10%+ Owner | 26 Mar 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Graydon Bensler | ELAB | Series B Preferred Stock | Award | 3,036,437 | 3,036,437 | 26 Mar 2025 | By GB Capital Ltd | |||
| Braeden Lichti | ELAB | Series B Preferred Stock | Award | 3,336,437 | 3,336,437 | 26 Mar 2025 | By Northstrive Companies Inc. | |||
| BWL Investments Ltd. | ELAB | Common Stock | Other | -45.7% | -1,656,000 | 1,967,965 | 28 Dec 2023 | Direct |